155 related articles for article (PubMed ID: 7718334)
1. A new 123I-MIBG whole body scan scoring method--application to the prediction of the response of metastases to induction chemotherapy in stage IV neuroblastoma.
Ady N; Zucker JM; Asselain B; Edeline V; Bonnin F; Michon J; Gongora R; Manil L
Eur J Cancer; 1995; 31A(2):256-61. PubMed ID: 7718334
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
3. Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
Suc A; Lumbroso J; Rubie H; Hattchouel JM; Boneu A; Rodary C; Robert A; Hartmann O
Cancer; 1996 Feb; 77(4):805-11. PubMed ID: 8616776
[TBL] [Abstract][Full Text] [Related]
4. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
[TBL] [Abstract][Full Text] [Related]
5. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
Matthay KK; Edeline V; Lumbroso J; Tanguy ML; Asselain B; Zucker JM; Valteau-Couanet D; Hartmann O; Michon J
J Clin Oncol; 2003 Jul; 21(13):2486-91. PubMed ID: 12829667
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
Messina JA; Cheng SC; Franc BL; Charron M; Shulkin B; To B; Maris JM; Yanik G; Hawkins RA; Matthay KK
Pediatr Blood Cancer; 2006 Dec; 47(7):865-74. PubMed ID: 16444675
[TBL] [Abstract][Full Text] [Related]
7. [123I-MIBG scintigraphy in patients with neuroblastoma].
Koizumi M; Sawada H; Goto M; Iijima A; Watari T; Kurosawa H; Kurumada H; Sugita K; Furukawa T
Kaku Igaku; 1994 May; 31(5):507-11. PubMed ID: 8028223
[TBL] [Abstract][Full Text] [Related]
8. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
Sautter-Bihl ML; Bihl H; Heinze HG
Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
[TBL] [Abstract][Full Text] [Related]
9. Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.
Frappaz D; Bonneu A; Chauvot P; Edeline V; Giammarile F; Siles S; Wioland M; Gomez F
Med Pediatr Oncol; 2000 Apr; 34(4):237-41. PubMed ID: 10742058
[TBL] [Abstract][Full Text] [Related]
10. [Follow up control of stage IV neuroblastoma: 123I-MIBG scintigraphy, bone scintigraphy and catecholamine metabolites].
Kohnert K; Lerch H; Thelen M; Jürgens H; Schober O
Nuklearmedizin; 1996 Dec; 35(6):220-4. PubMed ID: 8999421
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases.
Bouvier JF; Philip T; Chauvot P; Brunat Mentigny M; Ducrettet F; Maïassi N; Lahneche BE
Prog Clin Biol Res; 1988; 271():707-20. PubMed ID: 3261425
[TBL] [Abstract][Full Text] [Related]
12. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
[TBL] [Abstract][Full Text] [Related]
13. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma].
Guerra P
Pediatr Med Chir; 1990; 12(6):663-8. PubMed ID: 2093889
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
[TBL] [Abstract][Full Text] [Related]
16. What is the prognostic value of osteomedullary uptake on MIBG scan in neuroblastoma patients under one year of age?
Labreveux de Cervens C; Hartmann O; Bonnin F; Couanet D; Valteau-Couanet D; Lumbroso J; Behar C; Martelli H; Lemerele J
Med Pediatr Oncol; 1994; 22(2):107-14. PubMed ID: 8259095
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
Hadj-Djilani NL; Lebtahi NE; Delaloye AB; Laurini R; Beck D
Eur J Nucl Med; 1995 Apr; 22(4):322-9. PubMed ID: 7607262
[TBL] [Abstract][Full Text] [Related]
18. [Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].
Klingebiel T; Reuland P; Feine U; Niethammer D
Nuklearmedizin; 1992 Dec; 31(6):209-12. PubMed ID: 1491958
[TBL] [Abstract][Full Text] [Related]
19. Upper clavicular and cardiac meta-[123I]iodobenzylguanidine uptake in children.
Lumbroso J; Giammarile F; Hartmann O; Bonnin F; Parmentier C
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):17-20. PubMed ID: 9002743
[TBL] [Abstract][Full Text] [Related]
20. [Bone marrow metastases of neuroblastoma: MRT in comparison with bone marrow cytology and mIBG scintigraphy].
Benz-Bohm G; Gross-Fengels W; Widemann B; Linden A
Rofo; 1990 May; 152(5):523-7. PubMed ID: 2160683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
